{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:37:40Z","timestamp":1786984660889,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.apradiso.2025.112360","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:26:35Z","timestamp":1764980795000},"page":"112360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Low dose hyper-radiosensitivity as an intervention strategy to enhance 177Lu-iPSMA treatment in LNCaP cells"],"prefix":"10.1016","volume":"229","author":[{"given":"Consuelo","family":"Letechipia-de Le\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7520-461X","authenticated-orcid":false,"given":"Erika Patricia","family":"Azor\u00edn-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Areli","family":"Cabral-Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ordaz-Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Herrera-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apradiso.2025.112360_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.radphyschem.2022.110523","article-title":"Low dose hyper-radiosensitivity in normal human cells","volume":"202","author":"Almahwasi","year":"2023","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/j.apradiso.2025.112360_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.apradiso.2019.01.020","article-title":"Assessment of the radiation absorbed dose produced by 177Lu-iPSMA, 225Ac-iPSMA and 223RaCl2 to prostate cancer cell nuclei in a bone micro-environment model","volume":"146","author":"Azor\u00edn-Vega","year":"2019","journal-title":"Appl. Radiat. Isot."},{"issue":"8","key":"10.1016\/j.apradiso.2025.112360_bib3","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1021\/cr500171e","article-title":"Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications","volume":"115","author":"Banerjee","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.apradiso.2025.112360_bib4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/cancers11070905","article-title":"The nucleoshuttling of the ATM protein: a unified model to describe the individual response to High- and low-dose of radiation?","volume":"11","author":"Berthel","year":"2019","journal-title":"Cancers."},{"issue":"4","key":"10.1016\/j.apradiso.2025.112360_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1667\/RR2160.1","article-title":"Effects of low-dose radiation on the immune system of mice after total-body irradiation","volume":"174","author":"Bogd\u00e1ndi","year":"2010","journal-title":"Radiat. Res."},{"issue":"3","key":"10.1016\/j.apradiso.2025.112360_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-007-9329-z","article-title":"Pulsed reduced dose-rate radio-therapy case report: a novel re-treatment strategy in the management of recurrent glio-blastoma multiforme","volume":"83","author":"Cannon","year":"2007","journal-title":"J. Neuro Oncol."},{"issue":"5","key":"10.1016\/j.apradiso.2025.112360_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/ph15050590","article-title":"[99mTc]Tc-iFAP radioligand for SPECT\/CT imaging of the tumor microenvironment: Kinetics, radiation dosimetry, and imaging in patients","volume":"15","author":"Coria-Dom\u00ednguez","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.apradiso.2025.112360_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s13139-014-0315-z","article-title":"Production of (177)Lu for targeted radionuclide therapy: available options","volume":"49","author":"Dash","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.apradiso.2025.112360_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2023.111065","article-title":"Estimation of the relative biological effectiveness (RBE) of the 177Lu-iPSMA radiopharmaceutical","volume":"202","author":"De la Fuente-Mendoza","year":"2023","journal-title":"Appl. Radiat. Isot."},{"issue":"2","key":"10.1016\/j.apradiso.2025.112360_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/radiation5020010","article-title":"Effects induced in human cells and tissues by low doses of ionizing radiation: a review of vibrational spectroscopy contributions","volume":"5","author":"Delfino","year":"2025","journal-title":"Radiation"},{"key":"10.1016\/j.apradiso.2025.112360_bib11","series-title":"Proceedings of the 26th Annual Interna-tional Conference of the IEEE EMBS, San Francisco, 1-5 September 2004","first-page":"2758","article-title":"Soft-tissue material proper-ties under large deformation: strain rate effect","author":"Desai","year":"2004"},{"issue":"9","key":"10.1016\/j.apradiso.2025.112360_bib12","first-page":"1557","article-title":"Low-dose fractionated radiation potentiates the effects of paclitaxel in wild-type and mutant p53 head and neck tumor cell lines","author":"Dey","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.apradiso.2025.112360_bib13","first-page":"323","article-title":"A frakcion\u00e1lt besug\u00e1rz\u00e1s sug\u00e1r\u00e9rz\u00e9keny\u00edt\u00f4 hat\u00e1sa [Ra-diosensitizing effect of hyperfractionated radiation]","volume":"48","author":"Drahos","year":"2004","journal-title":"Magy. Onkol."},{"issue":"4","key":"10.1016\/j.apradiso.2025.112360_bib14","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is alpha\/beta for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.apradiso.2025.112360_bib15","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2967\/jnumed.124.268200","article-title":"Preclinical evaluation of 177Lu-OncoFAP-23, a multivalent FAP-targeted radiopharmaceutical therapeutic for solid tumors","volume":"65","author":"Galbiati","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2025.112360_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101710","article-title":"Low-dose radiotherapy effects in progression of anti-tumor response","volume":"35","author":"Gao","year":"2023","journal-title":"Transl. Oncol."},{"issue":"6","key":"10.1016\/j.apradiso.2025.112360_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2307\/3580211","article-title":"The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats","volume":"151","author":"Hashimoto","year":"1999","journal-title":"Radiat. Res."},{"issue":"13","key":"10.1016\/j.apradiso.2025.112360_bib18","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3390\/ijms20133212","article-title":"Tumor microenvironment as A \"Game Changer\" in cancer radiotherapy","volume":"20","author":"Jarosz-Biej","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.apradiso.2025.112360_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0360-3016(00)01471-1","article-title":"Low-dose hypersensitivity: current status and possible mechanisms","volume":"49","author":"Joiner","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"356","key":"10.1016\/j.apradiso.2025.112360_bib20","article-title":"Advances in the current understanding of how low-dose radiation affects the cell cycle","volume":"11","author":"Khan","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.apradiso.2025.112360_bib21","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3390\/pharmaceutics15122761","article-title":"DNA damage by radiopharmaceuticals and mechanisms of cel-lular repair","volume":"15","author":"Khazaei","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apradiso.2025.112360_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2025.112360_bib23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/RLU.0000000000003667","article-title":"Safety of fibroblast activation protein\u2013targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04","volume":"46","author":"Kuyumcu","year":"2021","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.apradiso.2025.112360_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/RLU.0000000000003667","article-title":"Safety of fibroblast activation protein\u2013targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04","volume":"46","author":"Kuyumcu","year":"2021","journal-title":"Clin. Nucl. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.apradiso.2025.112360_bib25","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.2967\/jnumed.118.220566","article-title":"Future of theranostics: an outlook on precision oncology in nuclear medicine","volume":"60","author":"Langbein","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"15","key":"10.1016\/j.apradiso.2025.112360_bib26","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.3390\/cancers15153979","article-title":"Influence of the hypersensitivity to low dose phenomenon on the tumor Re-sponse to hypofractionated stereotactic body radiation therapy","volume":"15","author":"Le Reun","year":"2023","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.apradiso.2025.112360_bib27","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1080\/15384101.2018.1520565","article-title":"P53 enhances apop-tosis induced by doxorubicin only under conditions of severe DNA damage","volume":"17","author":"Lin","year":"2018","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.apradiso.2025.112360_bib28","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.3390\/pharmaceutics15071988","article-title":"Improving overall survival and quality of life in patients with prostate cancer and neuroendocrine tumors using 177Lu-iPSMA and 177Lu-DOTATOC: experience after 905 treatment doses","volume":"15","author":"Luna-Guti\u00e9rrez","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apradiso.2025.112360_bib29","article-title":"Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.apradiso.2025.112360_bib30","first-page":"22","article-title":"Physics and dosimetric principles of SRS and SBRT","volume":"4","author":"Ma","year":"2019","journal-title":"Mathews J Cancer Sci"},{"issue":"1","key":"10.1016\/j.apradiso.2025.112360_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.rpor.2014.08.004","article-title":"Bystander effects and radiotherapy","volume":"20","author":"Mar\u00edn","year":"2014","journal-title":"Rep. Practical Oncol. Radiother."},{"issue":"1","key":"10.1016\/j.apradiso.2025.112360_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.rpor.2014.08.004","article-title":"Bystander effects and radiotherapy","volume":"20","author":"Mar\u00edn","year":"2014","journal-title":"Rep. Practical Oncol. Radiother."},{"key":"10.1016\/j.apradiso.2025.112360_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10495-016-1317-3","article-title":"Reduced risk of apoptosis: mechanisms of stress responses","volume":"2","author":"Milisav","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.apradiso.2025.112360_bib34","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1038\/ncomms6067","article-title":"Endoplasmic reticulum stress sensitizes cells to DNA damage-induced apoptosis through p53-dependent suppression of p21CDKN1A","volume":"5","author":"Mlynarczyk","year":"2014","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.apradiso.2025.112360_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14303","article-title":"Technical feasibility of novel immunostimulatory low-dose radiation for polymet-astatic disease with CBCT-based online adaptive and conventional approaches","volume":"25","author":"Nasser","year":"2024","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"10.1016\/j.apradiso.2025.112360_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2021.109898","article-title":"Comparison be-tween 177Lu-iPSMA and 225Ac-iPSMA dosimetry at a cellular level in an animal bone metastasis model","volume":"176","author":"Nava-Cabrera","year":"2021","journal-title":"Appl. Radiat. Isot."},{"issue":"3","key":"10.1016\/j.apradiso.2025.112360_bib37","first-page":"243","article-title":"The intersection between DNA damage response and cell death pathways","volume":"34","author":"Nowsheen","year":"2012","journal-title":"Exp. Oncol."},{"issue":"8","key":"10.1016\/j.apradiso.2025.112360_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/tomography11080083","article-title":"Emerging PET imaging agents and targeted radioligand therapy: a review of clinical applications and trials","volume":"11","author":"Palihati","year":"2025","journal-title":"Tomography"},{"issue":"602","key":"10.1016\/j.apradiso.2025.112360_bib39","doi-asserted-by":"crossref","first-page":"eabb3631","DOI":"10.1126\/scitranslmed.abb3631","article-title":"Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to im-mune checkpoint blockade","volume":"13","author":"Patel","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.apradiso.2025.112360_bib40","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.apradiso.2025.112360_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1541-7786.MCR-05-0074","article-title":"Fractionated low-dose radiation exposure leads to accumulation of DNA damage and profound alterations in DNA and histone methylation in the murine thymus","volume":"3","author":"Pogribny","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.apradiso.2025.112360_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41597-022-01653-3","article-title":"Datasets of in vitro\/clonogenic assays show-ing low dose hyper-radiosensitivity and induced radioresistance","volume":"9","author":"Polg\u00e1r","year":"2022","journal-title":"Sci. Data"},{"issue":"4","key":"10.1016\/j.apradiso.2025.112360_bib43","first-page":"287","article-title":"Exploiting sensitization win-dows of opportunity in hyper and hypo-fractionated radiation therapy","volume":"6","author":"Prasanna","year":"2014","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.apradiso.2025.112360_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijrobp.2009.10.008","article-title":"Confirmation of a low \u03b1\/\u03b2 ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics","volume":"79","author":"Proust-Lima","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.apradiso.2025.112360_bib45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1667\/0033-7587(2003)159[0433:LDRITF]2.0.CO;2","article-title":"Low-dose reduction in transformation frequency compared to unirradiated controls: the role of hyper-radiosensitivity to cell death","volume":"159","author":"Redpath","year":"2003","journal-title":"Radiat. Res."},{"issue":"1","key":"10.1016\/j.apradiso.2025.112360_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2203\/dose-response.11-002.Rithidech","article-title":"No evidence for the in vivo induction of genomic instability by low doses of 137Cs gamma rays in bone marrow cells of BALB\/cJ and C57BL\/6J mice","volume":"10","author":"Rithidech","year":"2012","journal-title":"Dose Response"},{"issue":"5","key":"10.1016\/j.apradiso.2025.112360_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/095530000138277","article-title":"Increased repair and cell survival in cells treated with DIR1 antisense oligonucle-otides: implications for induced radioresistance","volume":"76","author":"Robson","year":"2000","journal-title":"Int. J. Radiat. Biol."},{"issue":"12","key":"10.1016\/j.apradiso.2025.112360_bib48","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3109\/09553002.2013.825061","article-title":"De-termining if low dose hyper-radiosensitivity (HRS) can be exploited to provide a thera-peutic advantage: a cell line study in four glioblastoma multiforme (GBM) cell lines","volume":"89","author":"Schoenherr","year":"2013","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.apradiso.2025.112360_bib49","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fonc.2019.00156","article-title":"Novel approaches to improve the efficacy of Immuno-radiotherapy","volume":"9","author":"Shevtsov","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.apradiso.2025.112360_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/1559325818777326","article-title":"The lowest radiation dose having molecular changes in the living body","volume":"16","author":"Shimura","year":"2018","journal-title":"Dose Response"},{"issue":"6","key":"10.1016\/j.apradiso.2025.112360_bib51","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/09553000110041326","article-title":"Low-dose hypersensitivity after fractionated low-dose irradiation in vitro","volume":"77","author":"Short","year":"2001","journal-title":"Int. J. Radiat. Biol."},{"issue":"1\u20134","key":"10.1016\/j.apradiso.2025.112360_bib52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/rpd\/ncl427","article-title":"Evidence of low-dose hy-per-radiosensitivity in normal cells of cervix cancer patients?","volume":"122","author":"Slonina","year":"2006","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.apradiso.2025.112360_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820935525","article-title":"Delivery of radi-ation at the lowest dose rate by a modern linear accelerator is Most effective in inhib-iting prostate cancer growth","volume":"19","author":"Tazat","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.apradiso.2025.112360_bib55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/09553002.2013.800248","article-title":"Impact of dose-rate on the low-dose hyper-radiosensitivity and induced radioresistance (HRS\/IRR) response","volume":"89","author":"Thomas","year":"2014","journal-title":"Int. J. Radiat. Biol."},{"issue":"2","key":"10.1016\/j.apradiso.2025.112360_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(84)80048-1","article-title":"Dose-response curve and split-dose recovery in human skin cancer","volume":"2","author":"Trott","year":"1984","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.apradiso.2025.112360_bib57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/molecules27010264","article-title":"Design, synthesis and preclinical assessment of 99mTc-iFAP for in vivo fibroblast activation protein (FAP) imaging","volume":"27","author":"Trujillo-Ben\u00edtez","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.apradiso.2025.112360_bib58","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1054\/bjoc.2000.1258","article-title":"Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation","volume":"83","author":"Vaganay-Ju\u00e9ry","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.apradiso.2025.112360_bib59","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.radonc.2011.07.017","article-title":"Long-term biochemical control of prostate cancer after standard or hy-per-fractionation: evidence for different outcomes between low-intermediate and high risk patients","volume":"101","author":"Valdagni","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.apradiso.2025.112360_bib60","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1158\/1078-0432.CCR-18-2581","article-title":"The reciprocity between radiotherapy and cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.apradiso.2025.112360_bib61","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1631\/jzus.B2100079","article-title":"Insertion\/deletion variants within the IGF2BP2 gene identified in reported genome-wide selective sweep analysis reveal a correlation with goat litter size","volume":"22","author":"Xin","year":"2021","journal-title":"J. Zhejiang Univ. - Sci. B"},{"issue":"142","key":"10.1016\/j.apradiso.2025.112360_bib62","first-page":"1","article-title":"Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804325007055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804325007055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:53:24Z","timestamp":1769630004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804325007055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":61,"alternative-id":["S0969804325007055"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2025.112360","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low dose hyper-radiosensitivity as an intervention strategy to enhance 177Lu-iPSMA treatment in LNCaP cells","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2025.112360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112360"}}